Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Saegis Pharmaceuticals, Inc

Saegis is a development-stage company focused on the discovery of drugs to address behavioral disorders. Saegis has clinically evaluated three small molecule drugs and has a growing pipeline of novel treatments for central nervous system (CNS) diseases involving cognitive dysfunction.The company's focus is on Alzheimer's Disease (AD), Mild Cognitive Impairment (MCI), Cognitive Impairment Associated with Schizophrenia (CIAS), and Attention Deficit Hyperactivity Disorder (ADHD). By developing a new generation of CNS therapeutics, Saegis is committed to giving new hope to patients facing memory loss and cognition deficits associated with aging, psychiatric disorders and brain trauma.
Saegis' research is focused on understanding the widely observed phenomena that many individuals age "gracefully" (i.e. maintain their intellectual sharpness and memory) while a sizable portion of the population experiences a decline in cognitive ability over time. To date, the search for drugs to effectively treat cognitive decline associated with aging has been hindered by the lack of a research approach that closely mirrors the human condition.


Contact Details:
60 Stone Pine Road, Suite 200
Half Moon Bay
California
94019
United States of America
Tel:650-560-0210
Fax:650-560-0211
Email:info@saegispharma.com
WWW:

www.saegispharma.com/




Loading...

BioNews Results for Saegis Pharmaceuticals, Inc:

Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare Conference
Pharma Live:  Nov 23 2009 2:24AM Matching: pharmaceuticals inc
Analyst Choice Brings New Analysis on Level 3 Communications Inc., Arris Group Inc., Virgin Media Inc., The South Financial Group Inc., Wynn Resorts Limited and AMAG Pharmaceuticals Inc.
Individual.com:  Nov 21 2009 6:41AM Matching: pharmaceuticals inc
Ironwood Pharmaceuticals Files Registration Statement for Initial Public Offering
RBC Dain Rauscher:  Nov 21 2009 12:46AM Matching: pharmaceuticals inc
FDA approves sNDA for pediatric autism drug ABILIFY
News-Medical.Net:  Nov 21 2009 4:57AM Matching: pharmaceuticals inc
Global market for anti-depressants on a decline
News-Medical.Net:  Nov 20 2009 11:09AM Matching: pharmaceuticals inc
Promote your company here: BioNewsCast - Press Release Distribution

View more Saegis Pharmaceuticals, Inc news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 894 times since April 2007, the link to the organisation's website has been followed 240 times

Recent Search Terms used to find this page: Saegis Pharmaceutical website | saegis pharmaceuticals | Saegis Pharmaceuticals website | saegis pharmaceuticals | Saegis Pharmaceuticals | saegis pharmaceutics | Saegis Pharmaceuticals | Saegis Pharmaceuticals Inc. | Saegis Pharmaceuticals Inc. | Saegis Pharmaceuticals 2009 | .

Search for more companies in Half Moon Bay

Search for more companies in California



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Saegis Pharmaceuticals, Inc

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.